共 5 条
血清胸苷激酶1对Ⅳ期结肠癌化疗疗效评估的价值
被引:5
作者:

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:
机构:
[1] 苏州大学附属常州肿瘤医院肿瘤实验室及肿瘤内科
来源:
关键词:
血清胸苷激酶1;
结肠癌;
临床疗效;
D O I:
暂无
中图分类号:
R735.35 [];
学科分类号:
摘要:
目的分析血清胸苷激酶1(S-TK1)对Ⅳ期结肠癌患者化疗疗效评估的价值。方法采用免疫印迹增强化学发光法检测61例Ⅳ期结肠癌患者和41例健康体检者的S-TK1水平。结果Ⅳ期结肠癌患者的S-TK1水平[(3.47±2.33)pmol·L-1]高于健康体检者[(1.07±0.87)pmol·L-1](P<0.05);S-TK1水平与Ⅳ期结肠癌患者的ECOG评分有关(P<0.05);与化疗前比较,化疗后获得疾病控制的Ⅳ期结肠癌患者S-TK1水平呈下降趋势(P<0.05),PD患者S-TK1水平明显上升(P<0.05)。结论监测S-TK1水平对预测Ⅳ期结肠癌的化疗疗效具有一定的价值。
引用
收藏
页码:6 / 8
页数:3
相关论文
共 5 条
[1]
Changes in serum thymidine kinase 1 levels during chemotherapy correlate with objective response in patients with advanced gastric cancer
[J].
Liu, Yongping
;
Ling, Yang
;
Qi, Qiufeng
;
Tang, Yexin
;
Xu, Jianzhong
;
Zhou, Tong
;
Sheng, Guifeng
;
Yang, Quanliang
;
Pan, Yaodong
.
EXPERIMENTAL AND THERAPEUTIC MEDICINE,
2011, 2 (06)
:1177-1181

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:

Tang, Yexin
论文数: 0 引用数: 0
h-index: 0
机构:
Suzhou Univ, Changzhou Tumor Hosp, Clin Oncol Lab, Changzhou 213002, Peoples R China Suzhou Univ, Changzhou Tumor Hosp, Clin Oncol Lab, Changzhou 213002, Peoples R China

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:
[2]
Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings
[J].
Chen, Yan
;
Ying, Mingang
;
Chen, YanSong
;
Hu, Minhua
;
Lin, Yingying
;
Chen, Dedong
;
Li, Xiaoli
;
Zhang, Ming
;
Yun, Xia
;
Zhou, Ji
;
He, Ellen
;
Skog, Sven
.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY,
2010, 15 (04)
:359-368

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:

Hu, Minhua
论文数: 0 引用数: 0
h-index: 0
机构:
Fujian Med Univ, Teaching Hosp, Fujian Canc Hosp, Lab Biochem & Mol Biol Res, Fuzhou 350014, Fujian, Peoples R China Fujian Med Univ, Teaching Hosp, Fujian Canc Hosp, Lab Biochem & Mol Biol Res, Fuzhou 350014, Fujian, Peoples R China

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:

Zhang, Ming
论文数: 0 引用数: 0
h-index: 0
机构:
Sino Swed Mol Biomed Res Inst, Shenzhen 518057, Peoples R China Fujian Med Univ, Teaching Hosp, Fujian Canc Hosp, Lab Biochem & Mol Biol Res, Fuzhou 350014, Fujian, Peoples R China

Yun, Xia
论文数: 0 引用数: 0
h-index: 0
机构:
Sino Swed Mol Biomed Res Inst, Shenzhen 518057, Peoples R China Fujian Med Univ, Teaching Hosp, Fujian Canc Hosp, Lab Biochem & Mol Biol Res, Fuzhou 350014, Fujian, Peoples R China

Zhou, Ji
论文数: 0 引用数: 0
h-index: 0
机构:
Sino Swed Mol Biomed Res Inst, Shenzhen 518057, Peoples R China Fujian Med Univ, Teaching Hosp, Fujian Canc Hosp, Lab Biochem & Mol Biol Res, Fuzhou 350014, Fujian, Peoples R China

He, Ellen
论文数: 0 引用数: 0
h-index: 0
机构:
Sino Swed Mol Biomed Res Inst, Shenzhen 518057, Peoples R China Fujian Med Univ, Teaching Hosp, Fujian Canc Hosp, Lab Biochem & Mol Biol Res, Fuzhou 350014, Fujian, Peoples R China

Skog, Sven
论文数: 0 引用数: 0
h-index: 0
机构:
Sino Swed Mol Biomed Res Inst, Shenzhen 518057, Peoples R China Fujian Med Univ, Teaching Hosp, Fujian Canc Hosp, Lab Biochem & Mol Biol Res, Fuzhou 350014, Fujian, Peoples R China
[3]
Serum thymidine kinase 1 reflects the progression of pre-malignant and malignant tumors during therapy
[J].
Xu, Xiao-Hong
;
Zhang, Yi-Min
;
Shu, Xin-Hua
;
Shan, Lu-Hu
;
Wang, Zi-Wei
;
Zhou, Yong-Lie
;
Wen, Huai-Kai
;
He, Fan
;
He, Ellen
;
Skog, Sven
.
MOLECULAR MEDICINE REPORTS,
2008, 1 (05)
:705-711

Xu, Xiao-Hong
论文数: 0 引用数: 0
h-index: 0
机构:
Zhejiang Canc Hosp, Dept Clin & Lab Med, Hangzhou, Zhejiang, Peoples R China Zhejiang Canc Hosp, Dept Clin & Lab Med, Hangzhou, Zhejiang, Peoples R China

Zhang, Yi-Min
论文数: 0 引用数: 0
h-index: 0
机构:
Zhejiang Canc Hosp, Dept Clin & Lab Med, Hangzhou, Zhejiang, Peoples R China Zhejiang Canc Hosp, Dept Clin & Lab Med, Hangzhou, Zhejiang, Peoples R China

Shu, Xin-Hua
论文数: 0 引用数: 0
h-index: 0
机构:
Zhejiang Canc Hosp, Dept Clin & Lab Med, Hangzhou, Zhejiang, Peoples R China Zhejiang Canc Hosp, Dept Clin & Lab Med, Hangzhou, Zhejiang, Peoples R China

Shan, Lu-Hu
论文数: 0 引用数: 0
h-index: 0
机构:
Zhejiang Canc Hosp, Dept Clin & Lab Med, Hangzhou, Zhejiang, Peoples R China Zhejiang Canc Hosp, Dept Clin & Lab Med, Hangzhou, Zhejiang, Peoples R China

Wang, Zi-Wei
论文数: 0 引用数: 0
h-index: 0
机构:
Hangzhou First Peoples Hosp, Cent Lab, Hangzhou, Peoples R China Zhejiang Canc Hosp, Dept Clin & Lab Med, Hangzhou, Zhejiang, Peoples R China

Zhou, Yong-Lie
论文数: 0 引用数: 0
h-index: 0
机构:
Zhejiang Prov Peoples Hosp, Dept Clin & Lab Med, Hangzhou, Zhejiang, Peoples R China Zhejiang Canc Hosp, Dept Clin & Lab Med, Hangzhou, Zhejiang, Peoples R China

Wen, Huai-Kai
论文数: 0 引用数: 0
h-index: 0
机构: Zhejiang Canc Hosp, Dept Clin & Lab Med, Hangzhou, Zhejiang, Peoples R China

He, Fan
论文数: 0 引用数: 0
h-index: 0
机构:
Zhejiang Ctr Dis Control, Hangzhou, Zhejiang, Peoples R China Zhejiang Canc Hosp, Dept Clin & Lab Med, Hangzhou, Zhejiang, Peoples R China

He, Ellen
论文数: 0 引用数: 0
h-index: 0
机构:
Karolinska Inst, Dept Oncol, S-10401 Stockholm, Sweden Zhejiang Canc Hosp, Dept Clin & Lab Med, Hangzhou, Zhejiang, Peoples R China

Skog, Sven
论文数: 0 引用数: 0
h-index: 0
机构:
Karolinska Inst, Dept Oncol, S-10401 Stockholm, Sweden Zhejiang Canc Hosp, Dept Clin & Lab Med, Hangzhou, Zhejiang, Peoples R China
[4]
Thymidine kinase 1: A proliferation marker for determining prognosis and monitoring the surgical outcome of primary bladder carcinoma patients
[J].
Zhang, J
;
Jia, QN
;
Zou, S
;
Zhang, PG
;
Zhang, XB
;
Skog, S
;
Luo, PC
;
Zhang, W
;
He, QM
.
ONCOLOGY REPORTS,
2006, 15 (02)
:455-461

Zhang, J
论文数: 0 引用数: 0
h-index: 0
机构: Huddinge Univ Hosp, Karolinska Inst, Clin Res Ctr, Dept Oncol,Clin Res Lab, S-14186 Huddinge, Sweden

Jia, QN
论文数: 0 引用数: 0
h-index: 0
机构: Huddinge Univ Hosp, Karolinska Inst, Clin Res Ctr, Dept Oncol,Clin Res Lab, S-14186 Huddinge, Sweden

Zou, S
论文数: 0 引用数: 0
h-index: 0
机构: Huddinge Univ Hosp, Karolinska Inst, Clin Res Ctr, Dept Oncol,Clin Res Lab, S-14186 Huddinge, Sweden

Zhang, PG
论文数: 0 引用数: 0
h-index: 0
机构: Huddinge Univ Hosp, Karolinska Inst, Clin Res Ctr, Dept Oncol,Clin Res Lab, S-14186 Huddinge, Sweden

Zhang, XB
论文数: 0 引用数: 0
h-index: 0
机构: Huddinge Univ Hosp, Karolinska Inst, Clin Res Ctr, Dept Oncol,Clin Res Lab, S-14186 Huddinge, Sweden

Skog, S
论文数: 0 引用数: 0
h-index: 0
机构: Huddinge Univ Hosp, Karolinska Inst, Clin Res Ctr, Dept Oncol,Clin Res Lab, S-14186 Huddinge, Sweden

Luo, PC
论文数: 0 引用数: 0
h-index: 0
机构: Huddinge Univ Hosp, Karolinska Inst, Clin Res Ctr, Dept Oncol,Clin Res Lab, S-14186 Huddinge, Sweden

Zhang, W
论文数: 0 引用数: 0
h-index: 0
机构: Huddinge Univ Hosp, Karolinska Inst, Clin Res Ctr, Dept Oncol,Clin Res Lab, S-14186 Huddinge, Sweden

He, QM
论文数: 0 引用数: 0
h-index: 0
机构:
Huddinge Univ Hosp, Karolinska Inst, Clin Res Ctr, Dept Oncol,Clin Res Lab, S-14186 Huddinge, Sweden Huddinge Univ Hosp, Karolinska Inst, Clin Res Ctr, Dept Oncol,Clin Res Lab, S-14186 Huddinge, Sweden
[5]
THYMIDINE KINASE - A TUMOR-MARKER WITH PROGNOSTIC VALUE FOR NON-HODGKINS-LYMPHOMA AND A BROAD RANGE OF POTENTIAL CLINICAL-APPLICATIONS
[J].
HALLEK, M
;
WANDERS, L
;
STROHMEYER, S
;
EMMERICH, B
.
ANNALS OF HEMATOLOGY,
1992, 65 (01)
:1-5

HALLEK, M
论文数: 0 引用数: 0
h-index: 0
机构:
HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115 HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115

WANDERS, L
论文数: 0 引用数: 0
h-index: 0
机构:
HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115 HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115

STROHMEYER, S
论文数: 0 引用数: 0
h-index: 0
机构:
HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115 HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115

EMMERICH, B
论文数: 0 引用数: 0
h-index: 0
机构:
HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115 HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115
